SCHEMBL19491397

SCHEMBL19491397

C=Cc1ccc(C(=O)Nc2ccccc2NC(=O)Nc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 2/20 0.55
▸ HDAC2 Q92769 4/20 0.52
▸ HDAC1 Q13547 3/20 0.52
▸ HDAC3 O15379 2/20 0.52
▸ NCOR2 Q9Y618 1/20 0.52
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ POLB P06746 1/20 0.49
▸ CTDSP1 Q9GZU7 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ PTPN1 P18031 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ EPHX1 P07099 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ EPHX2 P34913 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19501832 0.90 SIRT1 (0.70) SIRT1HDAC2MEN1KMT2ANPC1
SCHEMBL26417130 0.86 PTPN1 (0.65) SIRT1HDAC2HDAC1HDAC3NCOR2
SCHEMBL19491398 0.86 SIRT1 (0.72) SIRT1MEN1KMT2AKDM4EPOLB
SCHEMBL19491365 0.85 SIRT1 (0.76) SIRT1HDAC2HDAC1HDAC3NCOR2
SCHEMBL19501531 0.83 SIRT1 (0.64) SIRT1HDAC2HDAC1HDAC3NCOR2
SCHEMBL5082916 0.83 SMN1; SMN2 (0.65) SIRT1MEN1KMT2ANPC1RAB9A
SCHEMBL19491373 0.82 PTPN1 (0.69) SIRT1HDAC2HDAC1HDAC3NCOR2
SCHEMBL19491391 0.81 KMT2A (0.62) SIRT1HDAC2HDAC1HDAC3NCOR2
SCHEMBL19491368 0.81 NPC1 (0.63) SIRT1HDAC2HDAC1HDAC3NCOR2
SCHEMBL9197688 0.80 PTPN1 (0.65) SIRT1HDAC2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10343438-B2 Heat-sensitive recording material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2019-07-09 — — US disclosed
US-20170297355-A1 Heat-Sensitive Recording Material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2017-10-19 — — US disclosed
US-20170297355-A1 Heat-Sensitive Recording Material NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2017-10-19 — — US disclosed
US-20150328220-A1 METHODS OF TREATING CHRONIC KIDNEY DISEASE CHARACTERIZED BY MACROALBUMINURIA CONCERT PHARMACEUTICALS, INC. 2015-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170297355-A1 Heat-Sensitive Recording Material SCN1A, SCN3A, KCNN3 SIRT1 1247/4885HDAC2 1449/4885HDAC1 1477/4885
US-20150328220-A1 METHODS OF TREATING CHRONIC KIDNEY DISEASE CHARACTERIZED BY MACROALBUMINURIA REN, ATP6V1B1, GLS SIRT1 537/4885HDAC2 2237/4885HDAC1 1498/4885
US-10343438-B2 Heat-sensitive recording material SCN1A, SCN3A, KCNN3 SIRT1 1247/4885HDAC2 1449/4885HDAC1 1477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback